Tag: Prescription Drugs
COVID-19 Antibody Cocktail Begins Late-Stage Human Trials
Trial will assess whether it can prevent infection among uninfected people in close contact with an infected person
CRC Risk Down With ACEi, Angiotensin Receptor Blocker Use
5 percent reduction in adjusted hazard ratio risk with each single year increase in drug use
Roughly 2 Million Americans Buy Prescriptions From Outside the Country
Patient education, stringent quality control measures necessary to ensure safe purchases
U.S. Grab of Only COVID-19 Treatment Outrages Health Experts
Behavior sets a dangerous precedent for attempts to share scarce treatments during the pandemic, experts warn
2005 to 2016 Saw Increase in Skeletal Muscle Relaxant Use
Office visits with prescribed SMR nearly doubled; tripling in visits for continued SMR drug therapy
Comparative Effectiveness of Treatments Explored in T2DM
Greatest drop in HbA1c for insulin, specific glucagon-like peptide-1 receptor agonist added to metformin
COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient
In the U.S., government programs, additional Gilead assistance should mean all patients have access to the drug
Colchicine May Improve Time to Clinical Deterioration in COVID-19
Significant improvement seen in time to clinical deterioration for hospitalized patients with COVID-19
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
Inhibition of Sclerostin May Increase Cardiovascular Risk
SOST genetic variants linked to lower risk for fracture and osteoporosis but higher risk for MI, major CV AEs
